Keywords: fomivirsen, delays, cmv, retinitis, progression, isis, pharmaceuticals

Fomivirsen Delays CMV Retinitis Progression

Article | 08 April 1998

Print This

Isis Pharmaceuticals and Ciba Vision, a unit of Novartis, have revealeddata from Phase III trials which demonstrate that the antisense ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in